Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - RPG Art Foundation unveils ‘Overshoot — Leaning Ecologies’ at Nariman Point, MumbaiHon’ble Shri Rahul Narwekar, Speaker of the Maharashtra Legislative Assembly, inaugurates Arunkumar H G’s new public art installation - Gaja Alternative Asset Management Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, August 19, 2026Price Band has been fixed from ₹ 152 to ₹ 160 per Equity Share - Horizon Industrial Parks Limited Announced its Initial Public Offer (IPO) to open on Monday, August 17, 2026 Price Band has been fixed at ₹ 57 to ₹ 60 per Equity Share - Shankesh Jewellers Limited Announced its Initial Public Offering (IPO) to open on Tuesday, August 18, 2026, Price Band fixed at ₹ 88 to ₹ 93 per equity share of the face value of ₹5 each - MILKY MIST DAIRY FOOD LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES TO OPEN ON TUESDAY 11 AUGUST 2026Price Band fixed at ₹133 to ₹140 per equity share of face value of ₹2 each - Shiprocket Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, August 12, 2026 Price Band has been fixed from ₹ 92 to ₹ 97 per Equity Share - Paramotor Digital Technology expands distribution of Digital Prepaid Payment Solutions with Aditya Birla Capital Digital products - Molbio Diagnostics Limited Announced its Initial public offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 768 per equity share of face value ₹1 each to ₹ 807 per equity share of the face value of ₹1 each - US Federal Contractor Tryfacta Achieves Final CMMC Level 2 (C3PAO) Certification, Strengthening Its Commitment to the U.S. Defense Industrial Base - Dhoot Transmission Limited Announced its Initial Public Offering (IPO) to open on Monday, August 10, 2026 Price Band fixed at ₹ 829 per equity share of face value ₹2 each to ₹871 per equity share of the face value of ₹2 each

Victory! Central Government Committee Withdraws Plan to Use Stray Dogs for Drug Testing 

New Delhi, 12th October 2023 (GNI): In a watershed moment for animal welfare and scientific advancement, the Committee for Control and Supervision of Experiments on Animals (CCSEA) – a statutory body constituted under The Prevention of Cruelty to Animals Act, 1960 – has withdrawn until further orders its recommendation to use stray dogs in vaccine trials.  

Last year, PETA India raised serious concerns that the Committee’s recommendation would open the floodgates not only for stray dogs but also for other feral animals to be used in experiments, such as painful efficacy and toxicity testing, dissections, and demonstrations. In a letter, PETA India urged the CCSEA to withdraw its recommendation in favour of animal-free research methods. 

PETA India points out that using dogs in vaccine development, whether they are obtained from a breeding facility or taken from the streets, leads science down the wrong road. Extensive peer-reviewed literature has established that the results of tests on animals, including dogs, can’t reliably predict how humans will respond to new medicines, which ultimately delays the approval of effective treatments and cures for human health conditions. 

“Reliance on tests using stray dogs and other animals to predict human responses to vaccines, drugs, and treatments is scientifically unsound and deeply troubling on ethical grounds,” says PETA India Science Policy Advisor Dr Ankita Pandey. “We applaud the CCSEA for withdrawing a regressive policy that would have negatively affected science, animal welfare, and public health.” 

In its letter, PETA India pointed out that the recommendation to use stray dogs contravened the duties assigned to the CCSEA by the Government of India under Rule 10 of the Breeding of and Experiments on the Animals (Control and Supervision) Amendment Rules, 2006, which states that, except in rare circumstances, “an establishment shall acquire animal(s) for experiments from registered breeders only”. The CCSEA’s recommendation, the letter noted, contradicted policies adopted by the EU, the UK, the US, and Australia, which are India’s competitors in science and technology. 

This news release is available in Hindi here. 

PETA India – whose motto reads, in part, that “animals are not ours to experiment on” – opposes speciesism, a human-supremacist worldview. For more information, please visit PETAIndia.com or follow the group on X (formerly Twitter)Facebook, or Instagram. Ends

Be the first to comment on "Victory! Central Government Committee Withdraws Plan to Use Stray Dogs for Drug Testing "

Leave a comment

Your email address will not be published.


*